login
login

Europe Daily Bulletin No. 9507

22 September 2007
Contents Publication in full By article 16 / 39
GENERAL NEWS / (eu) eu/medicines

21/09/2007 (Agence Europe) - After analysis of the pharmacovigilance data available, the European Medicines Agency (EMEA) decided to recommend use limited to no more than 15 days for products containing nimesulide. This non-steroidal anti-inflammatory drug (NSAID) remains authorised to treat acute pain and invalidating conditions, but presents a major risk of hepatic toxicity in prolonged use. EMEA therefore calls for all boxes containing more than 30 tablets or doses to be withdrawn from...

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS
TIMETABLE